High Times certainly hasn’t had an easy time of it lately, so it’s probably no surprise that disgruntled investors of High Times have now lined up to air their grievances. The cohort, led by Mark C. Donius and Jill L. Donius, filed a class action lawsuit against High Times Holding …
This story was republished with permission from Crain’s Cleveland and written by Marcus Gilmer. Ohio is less than 24 hours out from the kickoff of recreational cannabis sales and now we know which 98 dispensaries will have the necessary license to participate. On Monday, August 5, Ohio’s Division of Cannabis Control announced the …
Ascend Wellness Holdings Inc. (CSE: AAWH.U) (OTCQX: AAWH) reported mixed second-quarter results on Monday, with revenue growth offset by declining profits amid more competition in some markets. The New York-based multistate operator posted revenue of $141.5 million for the quarter ending June 30, up 15% from a year earlier. However, …
Incannex Healthcare Inc. (Nasdaq: IXHL) has received approval from the US Food and Drug Administration (FDA) to begin its Phase 2 clinical trial studying psilocybin on patients with generalized anxiety disorder (GAD). The trial uses Incannex’s psilocybin compound known as PSX-001. The psilocybin treatment is also accompanied by psychotherapy. Incannex …